Post-extrasystolic potentiation and the force-frequency relationship: Differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure

Preston J. Phillips, Judith K. Gwathmey, Marc D Feldman, Frederick J. Schoen, William Grossman, James P. Morgan

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

We studied post-extrasystolic potentiation (PESP) and frequency potentiation (FP) of human working myocardium isolated from the ventricles of 10 patients with end-stage heart failure (CHF) and 17 non-failing controls (CTL). The contractility index was peak isometric tension developed in vitro by trabeculae carneae (CTL n = 34, CHF n = 31); programmed electrical stimulation was used to initiate as well as alter the timing relationship of the contractile events. While holding constant the total number of contractions per unit of time, we compared the augmentation of contractile performance that occurred upon doubling the stimulation frequency (FP) to that of changing the stimulation pattern (PESP). In the CTL group we found that FP and PESP differed in their ability to augment cardiac contractile performance, PESP being more effective; 105 ± 13% for PESP vs. 34 ± 11% (mean ± s.e.m.) for FP. In the CHF group, the inotropic response to PESP was similar to CTL; in contrast, the relative efficacy of FP (3 ± 3%) compared to PESP (81 ± 14%) was markedly diminished. Studies with positive inotropic agents revealed that the percent change in contractility induced by FP and PESP depends upon the relative inotropic state of the heart; however, the contractile response to PESP always equaled or exceeded those produced by clinically relevant concentrations of inotropic agents, particularly in CHF muscles. Agents that increase intracellular levels of adenosine 3′,5′-cyclic monophosphate reversed the FP abnormalities seen in the CHF group, suggesting that deficient production of this second messenger in heart failure may cause the abnormal force-frequency relationship in failing myocardium. We conclude that the differential responses of myopathic muscle to PESP and FP may be caused by abnormal restitution processes during diastole. Our results suggest that PESP may be an effective therapeutic modality for patients with severe heart failure who have failed to adequately respond to inotropic drugs, and may serve as a useful indicator of cardiac contractile reserve in these patients.

Original languageEnglish (US)
Pages (from-to)99-110
Number of pages12
JournalJournal of Molecular and Cellular Cardiology
Volume22
Issue number1
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Myocardium
Heart Failure
Muscles
Diastole
Second Messenger Systems
Adenosine
Electric Stimulation
Control Groups
Pharmaceutical Preparations
Therapeutics
In Vitro Techniques

Keywords

  • Adenylate cyclase activators
  • Cardiac glycosides
  • Force-interval relationship
  • Frequency potentiation
  • Post-extrasystolic potentiation

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Post-extrasystolic potentiation and the force-frequency relationship : Differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure. / Phillips, Preston J.; Gwathmey, Judith K.; Feldman, Marc D; Schoen, Frederick J.; Grossman, William; Morgan, James P.

In: Journal of Molecular and Cellular Cardiology, Vol. 22, No. 1, 1990, p. 99-110.

Research output: Contribution to journalArticle

@article{752bbe58f4ea4805a93ccd2edcca3da5,
title = "Post-extrasystolic potentiation and the force-frequency relationship: Differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure",
abstract = "We studied post-extrasystolic potentiation (PESP) and frequency potentiation (FP) of human working myocardium isolated from the ventricles of 10 patients with end-stage heart failure (CHF) and 17 non-failing controls (CTL). The contractility index was peak isometric tension developed in vitro by trabeculae carneae (CTL n = 34, CHF n = 31); programmed electrical stimulation was used to initiate as well as alter the timing relationship of the contractile events. While holding constant the total number of contractions per unit of time, we compared the augmentation of contractile performance that occurred upon doubling the stimulation frequency (FP) to that of changing the stimulation pattern (PESP). In the CTL group we found that FP and PESP differed in their ability to augment cardiac contractile performance, PESP being more effective; 105 ± 13{\%} for PESP vs. 34 ± 11{\%} (mean ± s.e.m.) for FP. In the CHF group, the inotropic response to PESP was similar to CTL; in contrast, the relative efficacy of FP (3 ± 3{\%}) compared to PESP (81 ± 14{\%}) was markedly diminished. Studies with positive inotropic agents revealed that the percent change in contractility induced by FP and PESP depends upon the relative inotropic state of the heart; however, the contractile response to PESP always equaled or exceeded those produced by clinically relevant concentrations of inotropic agents, particularly in CHF muscles. Agents that increase intracellular levels of adenosine 3′,5′-cyclic monophosphate reversed the FP abnormalities seen in the CHF group, suggesting that deficient production of this second messenger in heart failure may cause the abnormal force-frequency relationship in failing myocardium. We conclude that the differential responses of myopathic muscle to PESP and FP may be caused by abnormal restitution processes during diastole. Our results suggest that PESP may be an effective therapeutic modality for patients with severe heart failure who have failed to adequately respond to inotropic drugs, and may serve as a useful indicator of cardiac contractile reserve in these patients.",
keywords = "Adenylate cyclase activators, Cardiac glycosides, Force-interval relationship, Frequency potentiation, Post-extrasystolic potentiation",
author = "Phillips, {Preston J.} and Gwathmey, {Judith K.} and Feldman, {Marc D} and Schoen, {Frederick J.} and William Grossman and Morgan, {James P.}",
year = "1990",
doi = "10.1016/0022-2828(90)90975-8",
language = "English (US)",
volume = "22",
pages = "99--110",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Post-extrasystolic potentiation and the force-frequency relationship

T2 - Differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure

AU - Phillips, Preston J.

AU - Gwathmey, Judith K.

AU - Feldman, Marc D

AU - Schoen, Frederick J.

AU - Grossman, William

AU - Morgan, James P.

PY - 1990

Y1 - 1990

N2 - We studied post-extrasystolic potentiation (PESP) and frequency potentiation (FP) of human working myocardium isolated from the ventricles of 10 patients with end-stage heart failure (CHF) and 17 non-failing controls (CTL). The contractility index was peak isometric tension developed in vitro by trabeculae carneae (CTL n = 34, CHF n = 31); programmed electrical stimulation was used to initiate as well as alter the timing relationship of the contractile events. While holding constant the total number of contractions per unit of time, we compared the augmentation of contractile performance that occurred upon doubling the stimulation frequency (FP) to that of changing the stimulation pattern (PESP). In the CTL group we found that FP and PESP differed in their ability to augment cardiac contractile performance, PESP being more effective; 105 ± 13% for PESP vs. 34 ± 11% (mean ± s.e.m.) for FP. In the CHF group, the inotropic response to PESP was similar to CTL; in contrast, the relative efficacy of FP (3 ± 3%) compared to PESP (81 ± 14%) was markedly diminished. Studies with positive inotropic agents revealed that the percent change in contractility induced by FP and PESP depends upon the relative inotropic state of the heart; however, the contractile response to PESP always equaled or exceeded those produced by clinically relevant concentrations of inotropic agents, particularly in CHF muscles. Agents that increase intracellular levels of adenosine 3′,5′-cyclic monophosphate reversed the FP abnormalities seen in the CHF group, suggesting that deficient production of this second messenger in heart failure may cause the abnormal force-frequency relationship in failing myocardium. We conclude that the differential responses of myopathic muscle to PESP and FP may be caused by abnormal restitution processes during diastole. Our results suggest that PESP may be an effective therapeutic modality for patients with severe heart failure who have failed to adequately respond to inotropic drugs, and may serve as a useful indicator of cardiac contractile reserve in these patients.

AB - We studied post-extrasystolic potentiation (PESP) and frequency potentiation (FP) of human working myocardium isolated from the ventricles of 10 patients with end-stage heart failure (CHF) and 17 non-failing controls (CTL). The contractility index was peak isometric tension developed in vitro by trabeculae carneae (CTL n = 34, CHF n = 31); programmed electrical stimulation was used to initiate as well as alter the timing relationship of the contractile events. While holding constant the total number of contractions per unit of time, we compared the augmentation of contractile performance that occurred upon doubling the stimulation frequency (FP) to that of changing the stimulation pattern (PESP). In the CTL group we found that FP and PESP differed in their ability to augment cardiac contractile performance, PESP being more effective; 105 ± 13% for PESP vs. 34 ± 11% (mean ± s.e.m.) for FP. In the CHF group, the inotropic response to PESP was similar to CTL; in contrast, the relative efficacy of FP (3 ± 3%) compared to PESP (81 ± 14%) was markedly diminished. Studies with positive inotropic agents revealed that the percent change in contractility induced by FP and PESP depends upon the relative inotropic state of the heart; however, the contractile response to PESP always equaled or exceeded those produced by clinically relevant concentrations of inotropic agents, particularly in CHF muscles. Agents that increase intracellular levels of adenosine 3′,5′-cyclic monophosphate reversed the FP abnormalities seen in the CHF group, suggesting that deficient production of this second messenger in heart failure may cause the abnormal force-frequency relationship in failing myocardium. We conclude that the differential responses of myopathic muscle to PESP and FP may be caused by abnormal restitution processes during diastole. Our results suggest that PESP may be an effective therapeutic modality for patients with severe heart failure who have failed to adequately respond to inotropic drugs, and may serve as a useful indicator of cardiac contractile reserve in these patients.

KW - Adenylate cyclase activators

KW - Cardiac glycosides

KW - Force-interval relationship

KW - Frequency potentiation

KW - Post-extrasystolic potentiation

UR - http://www.scopus.com/inward/record.url?scp=0025215651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025215651&partnerID=8YFLogxK

U2 - 10.1016/0022-2828(90)90975-8

DO - 10.1016/0022-2828(90)90975-8

M3 - Article

C2 - 1691300

AN - SCOPUS:0025215651

VL - 22

SP - 99

EP - 110

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 1

ER -